Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated
- Status
- RECRUITING
- Phase
- PHASE3
Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)
- Status
- RECRUITING
- Phase
- PHASE1
Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
- Status
- RECRUITING
- Phase
- PHASE2
Towards Cure Via Only Ultra-short ICB in CSCC
- Status
- RECRUITING
- Phase
- PHASE2
Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
- Status
- RECRUITING
- Phase
- PHASE2
A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma
- Status
- RECRUITING
- Phase
- PHASE3
Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis
- Status
- RECRUITING
- Phase
- PHASE2
Real-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyngeal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Outcomes of Patients With Resectable Non-Small Cell Lung Cancer Receiving Neoadjuvant Nivolumab Plus Chemotherapy in France
- Status
- COMPLETED
- Phase
- N/A
Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
- Status
- RECRUITING
- Phase
- PHASE2